PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:22 AM ET

Sponsor Check › Person

DT
No photo found yet (own website and image search run after this page is viewed)

Daniel Tasse

Named as an officer, director or promoter on SEC Form D filings · NJ, MA · Oct 2, 2009 → Oct 11, 2017

4deals (issuers)
$541.3Mreported sold
283investors
9Form D filings
2009–2017years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Daniel Tasse is listed as an executive officer and director on 9 SEC Form D filings by 4 issuers between Oct 2009 and Oct 2017: Compound Holdings I, LLC (Chicago, IL — pharmaceuticals — 2014; $412M reported sold to 178 investors), IKARIA HOLDINGS INC (Clinton, NJ — pharmaceuticals — 2009; $54.9M reported sold to 75 investors), Alcresta Therapeutics, Inc. (Warren, NJ — biotechnology — 2016–2017; $50.9M reported sold to 19 investors) and Bellerophon Therapeutics, Inc. (Warren, NJ — pharmaceuticals — 2014–2017; $23.4M reported sold to 11 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 8 years. Across those companies the filings report $541.3M sold in total.

Listed alongside Adam Weinstein (4 shared filings), Andre Moura (4 shared filings), Aldo Belloni (3 shared filings), Alexey Margolin (3 shared filings), James Topper (3 shared filings) and 55 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.

1 of the issuers belongs to the sponsor group Madison Dearborn (97 issuers, $43.66B reported sold, 2009–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Madison Dearborn has 97 companies on file and $43.66B reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.

What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 9 public filings for Daniel Tasse and found 10 differences, 1 worth asking the sponsor about: Form D filed 84 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Daniel Tasse has not run yet — it is joining a line of 14,475 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

2 cases: 2 dismissed

Tasse v. Mayhue Corp. dismissed
District Court, S.D. Florida · No. 0:96-cv-06822 · Filed Jul 24, 1996 · Closed Oct 11, 1996 · Nature of suit: 190 Other contract actions
Role of Tasse: Plaintiff · Outcome: Terminated 1996-10-11 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); surname only in the caption; court in FL (not a filing state)
Tasse v. Mayhue Corp. dismissed
District Court, S.D. Florida · No. 0:96-cv-06369 · Filed Apr 9, 1996 · Closed Apr 16, 1996 · Nature of suit: 190 Other contract actions
Role of Tasse: Plaintiff · Outcome: Terminated 1996-04-16 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); surname only in the caption; court in FL (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Daniel Tasse..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

Janet Tasse Construction Co closed
United States Bankruptcy Court, C.D. California · No. 8:12-bk-15231 · Filed Apr 26, 2012 · Closed Apr 30, 2013
Role of Janet Tasse Construction Co: Debtor · Outcome: Case closed 2013-04-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); different first name (janet); court in CA (not a filing state)
Janet Tasse Construction Co closed
United States Bankruptcy Court, S.D. California · No. 10-11274 · Filed Jun 28, 2010 · Closed Jul 28, 2010
Role of Janet Tasse Construction Co: Debtor · Outcome: Case closed 2010-07-28 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); different first name (janet); court in CA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for Daniel Tasse — 1 worth asking about (compared 9 filings on Oct 24, 2026)

Worth asking · Mar 22, 2016 – Jun 14, 2016

Form D filed 84 days after the first sale — Alcresta Therapeutics, Inc.

The filing says the first sale was Mar 22, 2016. The Form D was filed Jun 14, 2016 — 84 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 69 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jun 14, 2016 ↗Alcresta Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Feb 21, 2014 – Jul 2, 2014

Daniel Tasse's role changed at Bellerophon Therapeutics, Inc.: executive officer, director → director

The Feb 21, 2014 filing lists Daniel Tasse as executive officer, director; the Jul 2, 2014 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 21, 2014 ↗Form D · Jul 2, 2014 ↗Daniel Tasse — PartnerFacts page ↗Bellerophon Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jun 14, 2016 – Oct 31, 2016

Offering amount changed between filings — Alcresta Therapeutics, Inc.

The Jun 14, 2016 filing says $49,389,680 offered; the Oct 31, 2016 Form D/A says $50,889,675.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jun 14, 2016 ↗Form D/A (later) · Oct 31, 2016 ↗Alcresta Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Sep 15, 2017 – Sep 25, 2017

No amendment in the last 12 months on an offering that may still be open — Alcresta Therapeutics, Inc. (latest filing Sep 25, 2017)

The latest filing for this offering is dated Sep 25, 2017 (first sale Sep 15, 2017). It reports $9,999,986 sold of $34,999,978 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Sep 25, 2017 ↗Alcresta Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 7, 2008 – Oct 2, 2009

No amendment in the last 12 months on an offering that may still be open — IKARIA HOLDINGS INC (latest filing Oct 2, 2009)

The latest filing for this offering is dated Oct 2, 2009 (first sale Jul 7, 2008). It reports $54,947,203 sold of an indefinite amount offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Oct 2, 2009 ↗IKARIA HOLDINGS INC — PartnerFacts page ↗
Sources
Note · Apr 17, 2025

Same name, different state: "Daniel Tasse" (I0) is a separate record

This page covers filings where the address state is NJ or MA. A separate record, "Daniel Tasse" with address state I0, is listed on 1 filing — most recently by DBV Technologies S.A. (Apr 17, 2025). The two records do not overlap in time: this page runs Oct 2, 2009 to Oct 11, 2017; the other has one filing dated Apr 17, 2025.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Daniel Tasse (I0) — PartnerFacts page ↗Form D · Apr 17, 2025 ↗DBV Technologies S.A. — PartnerFacts page ↗Daniel Tasse (NJ,MA) — this page ↗
Sources
Note · Dec 15, 2015 – Jan 10, 2020

Same name, different state: "Daniel Tasse" (CA) is a separate record

This page covers filings where the address state is NJ or MA. A separate record, "Daniel Tasse" with address state CA, is listed on 6 filings — most recently by BioQ Pharma Inc (Jan 10, 2020). Both records have filings in the same period (Dec 15, 2015 to Oct 11, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Daniel Tasse (CA) — PartnerFacts page ↗Form D · Jan 10, 2020 ↗BioQ Pharma Inc — PartnerFacts page ↗Daniel Tasse (NJ,MA) — this page ↗
Sources
Note · Oct 31, 2016 – Sep 25, 2017

Address moved from Newton, MA to Warren, NJ — Alcresta Therapeutics, Inc.

The people listed on the Oct 31, 2016 filing give Newton, MA; on the Sep 25, 2017 filing they give Warren, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D/A · Oct 31, 2016 ↗Form D · Sep 25, 2017 ↗Alcresta Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 2, 2014 – May 19, 2017

Address moved from Hampton, NJ to Warren, NJ — Bellerophon Therapeutics, Inc.

The people listed on the Jul 2, 2014 filing give Hampton, NJ; on the May 19, 2017 filing they give Warren, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 2, 2014 ↗Form D · May 19, 2017 ↗Bellerophon Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Oct 2, 2009 – Oct 11, 2017

Daniel Tasse is listed with 2 different address states: NJ, MA

NJ on 7 filings (Oct 2, 2009 to Oct 11, 2017); MA on 2 filings (Jun 14, 2016 to Oct 31, 2016).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D/A · Oct 2, 2009 ↗Form D · Jun 14, 2016 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 8 offerings report sales commissions totalling $860,000; 0 report finder's fees; 2 report proceeds to related persons totalling $66,043,927. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 11, 2017 D
Bellerophon Therapeutics, Inc.
File 021-296368
$650,000$0$0Theodore Wang BrokerCheck CRD 2786005 ↗
via Angel Pond Capital LLC (CRD 287761 ↗)
EDGAR ↗
Sep 25, 2017 D
Alcresta Therapeutics, Inc.
File 021-295327
$0$0$0None listed on this filingEDGAR ↗
May 19, 2017 D
Bellerophon Therapeutics, Inc.
File 021-287121
$210,000$0$0H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗EDGAR ↗
Oct 31, 2016 D/A
Alcresta Therapeutics, Inc.
File 021-264996
$0$0$1,043,927None listed on this filingEDGAR ↗
Jul 2, 2014 D
Bellerophon Therapeutics, Inc.
File 021-220220
$0$0$0None listed on this filingEDGAR ↗
Feb 24, 2014 D
Compound Holdings I, LLC
File 021-212385
$0$0$65,000,000 (est.)
An aggregate of approximately $65,000,000 in cash or equity has been or will be paid to executive officers in respect of the proceeds, transaction bonus, special dividend bonus, and LTIP amounts to which they are entitled under the Acquisition Agreement.
None listed on this filingEDGAR ↗
Feb 21, 2014 D
Bellerophon Therapeutics, Inc.
File 021-212315
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2009 D/A
IKARIA HOLDINGS INC
File 021-102325
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Daniel Tasse on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

BT
Pharmaceuticals

Bellerophon Therapeutics, Inc.

Warren, NJ · Feb 21, 2014 → Oct 11, 2017 · 4 filings
  • Oct 11, 2017 · D · $23,437,050 sold of $23,437,050 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 19, 2017 · D · $1,612,500 sold of $1,612,500 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 2, 2014 · D · $1 sold of $1 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 21, 2014 · D · $1 sold of $1 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $23.4M from 11 investors (100% of the $23.4M target) as of the latest filing. Daniel is listed as director, executive officer on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Biotechnology

Alcresta Therapeutics, Inc.

Warren, NJ · Jun 14, 2016 → Sep 25, 2017 · 3 filings
  • Sep 25, 2017 · D · $9,999,986 sold of $34,999,978 · 13 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Oct 31, 2016 · D/A · $50,889,675 sold of $50,889,675 · 13 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 14, 2016 · D · $49,389,680 sold of $49,389,680 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $50.9M from 19 investors (100% of the $35M target) as of the latest filing. Daniel is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CH
Pharmaceuticals · group: Madison Dearborn

Compound Holdings I, LLC

Chicago, IL · Feb 24, 2014
  • Feb 24, 2014 · D · $412,000,000 sold of $412,000,000 · 178 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $412M from 178 investors (100% of the $412M target) as of the latest filing. Daniel is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

IH
Pharmaceuticals

IKARIA HOLDINGS INC

Clinton, NJ · Oct 2, 2009
  • Oct 2, 2009 · D/A · $54,947,203 sold of Indefinite · 75 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $54.9M from 75 investors as of the latest filing. Daniel is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Daniel Tasse — CA, 1 issuer, Dec 15, 2015 → Jan 10, 2020 · no shared issuer
  • Daniel Tasse — France (as filed: I0), 1 issuer, Apr 17, 2025 → Apr 17, 2025 · no shared issuer

People around Daniel 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Weinstein

Director · 4 shared filings (1 issuer) · also on 84 other issuers

Adam Weinstein is on 85 issuers in total — a repeat sponsor. Their page lists every one.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Andre Moura

Director · 4 shared filings (1 issuer) · also on 19 other issuers

Andre Moura is on 20 issuers in total — a repeat sponsor. Their page lists every one.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Aldo Belloni

Director · 3 shared filings (2 issuers)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Alexey Margolin

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Scheinler

Executive Officer · 3 shared filings (2 issuers)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew S. Holt

Director · 3 shared filings (2 issuers) · also on 12 other issuers

Matthew S. Holt is on 14 issuers in total — a repeat sponsor. Their page lists every one.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Peacock

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Dubin

Director · 3 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

RN
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Nelsen

Director · 3 shared filings (2 issuers) · also on 37 other issuers

Robert Nelsen is on 39 issuers in total — a repeat sponsor. Their page lists every one.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James Topper

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

BR
No photo found yet (own website and image search run after this page is viewed)
Person

Bryan Roberts

Director · 2 shared filings (2 issuers) · also on 30 other issuers

Bryan Roberts is on 32 issuers in total — a repeat sponsor. Their page lists every one.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Ross

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James A. Briggs

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Gallotto

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Meglasson

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Reinilde Heyrman

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David Abrams

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

MN
No photo found yet (own website and image search run after this page is viewed)
Person

Manesh Naidu

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

HP
No photo found yet (own website and image search run after this page is viewed)
Person

Howard Pien

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jeremy Lack

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Krauss

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

TK
No photo found yet (own website and image search run after this page is viewed)
Person

Tasos Konidaris

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Bennett

Executive Officer · 2 shared filings (2 issuers) · also on 5 other issuers

Matthew Bennett is on 7 issuers in total — a repeat sponsor. Their page lists every one.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Paz

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Mary Ann Cloyd

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

FT
No photo found yet (own website and image search run after this page is viewed)
Person

Fabian Tenenbaum

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jens Luehring

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Dekker

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

DQ
No photo found yet (own website and image search run after this page is viewed)
Person

Deborah A. Quinn

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

AE
No photo found yet (own website and image search run after this page is viewed)
Person

Amy Edmonds

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Bruder

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

PF
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Fernandes

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Parag Shah

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

NA
No photo found yet (own website and image search run after this page is viewed)
Person

Naseem P. Amin

Director · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Megan Schoeps

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

JASON SHIDELER

Director · 1 shared filing (1 issuer) · also on 28 other issuers

JASON SHIDELER is on 29 issuers in total — a repeat sponsor. Their page lists every one.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

ELIZABETH Q. BETTEN

Director · 1 shared filing (1 issuer) · also on 42 other issuers

ELIZABETH Q. BETTEN is on 43 issuers in total — a repeat sponsor. Their page lists every one.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

TIMOTHY P. SULLIVAN

Director · 1 shared filing (1 issuer) · also on 59 other issuers

TIMOTHY P. SULLIVAN is on 60 issuers in total — a repeat sponsor. Their page lists every one.

NA
No photo found yet (own website and image search run after this page is viewed)
Person

NICHOLAS W. ALEXOS

Director · 1 shared filing (1 issuer) · also on 18 other issuers

NICHOLAS W. ALEXOS is on 19 issuers in total — a repeat sponsor. Their page lists every one.

EL
No photo found yet (own website and image search run after this page is viewed)
Person

Elizabeth A. Larkin

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Tasse. Their page shows their other deals.

The team behind the deals

MD
Sponsor group

Madison Dearborn

97 issuers · 232 filings · $43.66B reported sold · 2009–2026

One team, 97 deal companies. Daniel Tasse is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Daniel Tasse.

Same business address

14 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Daniel Tasse by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Daniel Tasse is listed on: none on file. No website or social profile named in Compound Holdings I, LLC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #321,669 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Chicago, IL). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗Massachusetts MassCourts ↗Cook County Clerk of Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗Massachusetts Secretary of State business search ↗Illinois Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Daniel Tasse appears on a new Form D, or when a court case or SEC action is matched to them. See plans →